Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Claudio Marasca and Gabriella Fabbrocini.
Claudio Marasca
Connection Strength
15.429
Gabriella Fabbrocini
  1. Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy. J Dermatolog Treat. 2022 Feb; 33(1):592.
    View in: PubMed
    Score: 0.884
  2. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study J Drugs Dermatol. 2019 May 01; 18(5):437-438.
    View in: PubMed
    Score: 0.821
  3. Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes". J Am Acad Dermatol. 2019 Mar 11.
    View in: PubMed
    Score: 0.813
  4. Secukinumab and hidradenitis suppurativa: Friends or foes? JAAD Case Rep. 2019 Feb; 5(2):184-187.
    View in: PubMed
    Score: 0.807
  5. Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb. Br J Dermatol. 2019 04; 180(4):950-951.
    View in: PubMed
    Score: 0.802
  6. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance. Br J Dermatol. 2019 04; 180(4):949.
    View in: PubMed
    Score: 0.802
  7. Insulin resistance, mTOR and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 03; 33(3):e106-e107.
    View in: PubMed
    Score: 0.792
  8. A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa. Open Access Maced J Med Sci. 2018 Oct 25; 6(10):1902-1905.
    View in: PubMed
    Score: 0.789
  9. Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clin Exp Dermatol. 2019 04; 44(3):e28-e29.
    View in: PubMed
    Score: 0.789
  10. Unconventional therapies for hidradenitis suppurativa. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):879-887.
    View in: PubMed
    Score: 0.783
  11. Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa. G Ital Dermatol Venereol. 2020 Apr; 155(2):234-235.
    View in: PubMed
    Score: 0.764
  12. A misdiagnosed case of furuncular myiasis in an Italian traveler returning from Kenya. G Ital Dermatol Venereol. 2018 Apr; 153(2):288-289.
    View in: PubMed
    Score: 0.761
  13. A case of axillary hidradenitis suppurativa treated with topical tacrolimus. G Ital Dermatol Venereol. 2019 Oct; 154(5):594-595.
    View in: PubMed
    Score: 0.752
  14. Zoon Balanitis in an immune-competent teenager. G Ital Dermatol Venereol. 2019 Apr; 154(2):221-223.
    View in: PubMed
    Score: 0.733
  15. Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e745-e747.
    View in: PubMed
    Score: 0.240
  16. Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects. Dermatol Ther. 2021 01; 34(1):e14677.
    View in: PubMed
    Score: 0.230
  17. Coronavirus disease and dermatology: current and future challenges. G Ital Dermatol Venereol. 2020 Oct; 155(5):683-684.
    View in: PubMed
    Score: 0.227
  18. Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients' quality of life. J Dermatolog Treat. 2020 Oct 12; 1-2.
    View in: PubMed
    Score: 0.227
  19. Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature. Minerva Endocrinol. 2020 Dec; 45(4):345-353.
    View in: PubMed
    Score: 0.226
  20. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic? Int J Dermatol. 2020 Sep; 59(9):1144-1145.
    View in: PubMed
    Score: 0.224
  21. Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e249.
    View in: PubMed
    Score: 0.221
  22. Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic. Clin Exp Dermatol. 2020 Aug; 45(6):749.
    View in: PubMed
    Score: 0.221
  23. May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? Med Hypotheses. 2020 Oct; 143:109853.
    View in: PubMed
    Score: 0.221
  24. Chronic cutaneous ulcers management in dermatologic department during COVID-19 era. Int Wound J. 2020 Oct; 17(5):1517-1518.
    View in: PubMed
    Score: 0.220
  25. Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears. J Dermatolog Treat. 2020 06; 31(4):328-329.
    View in: PubMed
    Score: 0.220
  26. Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast. Eur J Cancer. 2019 Mar; 110:107-109.
    View in: PubMed
    Score: 0.202
  27. Chemotherapy-induced periungual pyogenic granuloma: epidemiology and recurrence rates in our experience. G Ital Dermatol Venereol. 2018 Oct 11.
    View in: PubMed
    Score: 0.197
  28. Human Microbiome: Composition and Role in Inflammatory Skin Diseases. Arch Immunol Ther Exp (Warsz). 2019 Feb; 67(1):1-18.
    View in: PubMed
    Score: 0.197
  29. An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):749-753.
    View in: PubMed
    Score: 0.197
  30. New insights into mechanism of Notch signaling in hidradenitis suppurativa. G Ital Dermatol Venereol. 2020 Aug; 155(4):529-530.
    View in: PubMed
    Score: 0.194
  31. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018 Dec; 4(4):203-211.
    View in: PubMed
    Score: 0.193
  32. Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results. Support Care Cancer. 2018 May; 26(5):1353-1355.
    View in: PubMed
    Score: 0.189
  33. Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients. Open Access Maced J Med Sci. 2018 Jan 25; 6(1):31-34.
    View in: PubMed
    Score: 0.187
  34. Ultraviolet radiation, vitamin D, and COVID-19. Ital J Dermatol Venerol. 2021 Jun; 156(3):366-373.
    View in: PubMed
    Score: 0.059
  35. Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience. Support Care Cancer. 2020 Sep; 28(9):3991-3993.
    View in: PubMed
    Score: 0.055
  36. Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease. Nutrients. 2018 Dec 28; 11(1).
    View in: PubMed
    Score: 0.050
  37. Adult atopic dermatitis: new and emerging therapies. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):867-878.
    View in: PubMed
    Score: 0.049
  38. Update on pathogenesis of hidradenitis suppurativa. G Ital Dermatol Venereol. 2018 Jun; 153(3 Suppl 2):3-7.
    View in: PubMed
    Score: 0.048
  39. Photodynamic Therapy and Skin Appendage Disorders: A Review. Skin Appendage Disord. 2017 Jan; 2(3-4):166-176.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.